123 related articles for article (PubMed ID: 2566988)
41. The effects of histamine H2-receptor antagonists on PHA induced lymphocyte proliferation.
Vickers MR; Milliner KJ; Fallowfield C; Dracott BN
Agents Actions; 1984 Oct; 15(3-4):342-8. PubMed ID: 6084413
[TBL] [Abstract][Full Text] [Related]
42. A comparison of some of the pharmacological properties of etintidine, a new histamine H2-receptor antagonist, with those of cimetidine, ranitidine and tiotidine.
Cavanagh RL; Usakewicz JJ; Buyniski JP
J Pharmacol Exp Ther; 1983 Jan; 224(1):171-9. PubMed ID: 6129316
[TBL] [Abstract][Full Text] [Related]
43. Pharmacology of JB-9315, a new selective histamine H2-receptor antagonist.
Palacios B; Montero MJ; Sevilla MA; San Román L
Gen Pharmacol; 1998 Feb; 30(2):181-9. PubMed ID: 9502172
[TBL] [Abstract][Full Text] [Related]
44. JB-9322, a new selective histamine H2-receptor antagonist with potent gastric mucosal protective properties.
Palacios B; Montero MJ; Sevilla MA; Román LS
Br J Pharmacol; 1995 May; 115(1):57-66. PubMed ID: 7647984
[TBL] [Abstract][Full Text] [Related]
45. Morphobiochemical studies on alpha-amylase secretion by pancreatic follicles of guinea pigs after the application of exogenous histamine.
Kmieć BL; Andrysiak PK
Folia Histochem Cytobiol; 1997; 35(2):113-4. PubMed ID: 9151100
[No Abstract] [Full Text] [Related]
46. Effects of ORF 17583, other histamine H2-receptor antagonists and omeprazole on gastric acid secretory states in rats and dogs.
Katz LB; Tobia AJ; Shriver DA
J Pharmacol Exp Ther; 1987 Aug; 242(2):437-42. PubMed ID: 2886642
[TBL] [Abstract][Full Text] [Related]
47. Further observations on the motor activity of some new histamine H2-receptor antagonists on the digestive system.
Bertaccini G; Coruzzi G; Vizi ES
Int J Tissue React; 1983; 5(3):257-62. PubMed ID: 6140243
[TBL] [Abstract][Full Text] [Related]
48. Effects of H2-receptor antagonists on 3H-cimetidine binding and histamine-stimulation of cellular cAMP in isolated guinea pig gastric glands.
Tanaka A; Nishihara S; Misawa T; Ibayashi H
Jpn J Pharmacol; 1987 Sep; 45(1):97-105. PubMed ID: 2890783
[TBL] [Abstract][Full Text] [Related]
49. FR145715, a novel histamine H2 receptor antagonist, with specific anti-Helicobacter pylori activities.
Ishikawa H; Ito H; Higaki M; Higaki M; Matsumoto Y; Kamimura T; Katsura Y; Tomishi T; Inoue Y; Takasugi H; Tomoi M; Krakowka S; Yoshida K
Eur J Pharmacol; 1999 Aug; 378(3):299-310. PubMed ID: 10493106
[TBL] [Abstract][Full Text] [Related]
50. Cardiac and gastric effects of histamine H2 receptor antagonists: no evidence for a correlation between lipophilicity and receptor affinity.
Coruzzi G; Adami M; Pozzoli C; Giorgi F; Bertaccini G
Br J Pharmacol; 1996 Aug; 118(7):1813-21. PubMed ID: 8842448
[TBL] [Abstract][Full Text] [Related]
51. Effects of the selective H1 and H2 histamine receptor antagonists loratadine and ranitidine on autonomic control of the heart.
Nault MA; Milne B; Parlow JL
Anesthesiology; 2002 Feb; 96(2):336-41. PubMed ID: 11818765
[TBL] [Abstract][Full Text] [Related]
52. Synthesis and activity of pyridine analogues of histamine H2-receptor antagonists.
Agrawal VK; Tang SB; Wolowyk MW; Knaus EE
Drug Des Deliv; 1988 Dec; 3(4):297-307. PubMed ID: 2908227
[TBL] [Abstract][Full Text] [Related]
53. Irreversible H2-antagonism of the four isomeric butyl analogues of mifentidine.
Bastiaans HM; Donetti A; Kramer K; Bietti G; Cereda E; Dubini D; Mondini M; Bast A; Timmerman H
Agents Actions; 1990 Apr; 30(1-2):166-8. PubMed ID: 1973582
[TBL] [Abstract][Full Text] [Related]
54. Ranitidine bismuth citrate: a novel anti-ulcer agent with different physico-chemical characteristics and improved biological activity to a bismuth citrate-ranitidine admixture.
McColm AA; McLaren A; Klinkert G; Francis MR; Connolly PC; Grinham CJ; Campbell CJ; Selway S; Williamson R
Aliment Pharmacol Ther; 1996 Jun; 10(3):241-50. PubMed ID: 8791946
[TBL] [Abstract][Full Text] [Related]
55. A comparative study of the actions of histamine H2 receptor antagonists on transmission in the isolated superior cervical ganglion of the rat.
Alkadhi KA; Bassey EI; Hogan YH
Neuropharmacology; 1990 Mar; 29(3):285-90. PubMed ID: 1970132
[TBL] [Abstract][Full Text] [Related]
56. Potential histamine H2-receptor antagonists: synthesis and pharmacological activity of derivatives containing acylamino-furazan moieties.
Sorba G; Fruttero R; Di Stilo A; Gasco A; Orsetti M
Arch Pharm (Weinheim); 1992 Mar; 325(3):151-5. PubMed ID: 1353669
[TBL] [Abstract][Full Text] [Related]
57. [H2-antihistaminics. 34. 1,3,4-Oxadiazol-2,5-diamines with H2-antagonistic activity].
Krämer I; Szelenyi I; Schunack W
Arch Pharm (Weinheim); 1987 Feb; 320(2):120-30. PubMed ID: 2883956
[No Abstract] [Full Text] [Related]
58. Comparative study of the H2-receptor antagonists cimetidine, ranitidine, famotidine and nizatidine on the rabbit stomach fundus and sigmoid colon.
Kounenis G; Koutsoviti-Papadopoulou M; Elezoglou A; Voutsas A
J Pharmacobiodyn; 1992 Oct; 15(10):561-5. PubMed ID: 1362967
[TBL] [Abstract][Full Text] [Related]
59. Histamine analogues, XXXV: 2-substituted histamine derivatives containing classical moieties of H2-antagonists--a novel class of H1-agonists.
Zingel V; Elz S; Schunack W
Arch Pharm (Weinheim); 1993 Mar; 326(3):143-51. PubMed ID: 8097625
[TBL] [Abstract][Full Text] [Related]
60. Studies on MK-208 (YM-11170) a new, slowly dissociable H2-receptor antagonist.
Pendleton RG; Torchiana ML; Chung C; Cook P; Wiese S; Clineschmidt BV
Arch Int Pharmacodyn Ther; 1983 Nov; 266(1):4-16. PubMed ID: 6141772
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
